Piper Sandler Companies rises amid market strength
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 05 Jan 26
Source: 4
Piper Sandler Companies saw a price increase of 5.03% as it crossed above the 5-day SMA, reflecting positive momentum in the stock.
This movement is attributed to broad market strength, with the Nasdaq-100 up 0.87% and the S&P 500 up 0.70%. The overall market conditions have contributed to the stock's upward trajectory, indicating a favorable environment for investors.
The rise in Piper Sandler's stock price suggests that investors are responding positively to the broader market trends, which may lead to further interest in the company's performance in the upcoming trading sessions.
Analyst Views on PIPR
Wall Street analysts forecast PIPR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PIPR is 386.00 USD with a low forecast of 386.00 USD and a high forecast of 386.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 347.560
Low
386.00
Averages
386.00
High
386.00
Current: 347.560
Low
386.00
Averages
386.00
High
386.00
About PIPR
Piper Sandler Companies is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States and internationally. The Company operates in one segment, providing investment banking services, institutional sales and trading services for various equity and fixed income products, and research services. It provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. The Company operates alternative asset management funds in merchant banking and healthcare in order to invest firm capital and to manage capital from outside investors. It offers both equity and fixed income advisory and trade execution services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
